PDCD1 and neoplasm: Overall, these findings reveal that the inhibition of the TGFB signaling pathway can increase lymphocyte infiltration in tumor, thus bringing the tumor microenvironment to an inflammatory state, finally making it vulnerable to the PD-1/PD-L1 checkpoint blockade.